GH7-18072-06116
3 vaccinations
6 coded responses
32 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 609 / IL
- Registered
- 2021-06-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-02
Registered in v-safe
-
2021-06-02
Dose 1 — Pfizer-BioNTech
- 2021-06-02
- 2021-06-03
- 2021-06-04
- 2021-06-05
- 2021-06-06
- 2021-06-08
- 2021-06-09
- 2021-06-16
-
2021-06-23
Survey response — day 21, dose 1MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Sore throat, cough, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-30
-
2021-07-08
Dose 2 — Pfizer-BioNTech
-
2021-07-08
Health check-in — day 0, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-07-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
-
2021-07-22
Survey response — day 14, dose 2MedDRA: Cough, Oropharyngeal pain — Feeling: FairFree text: Sore throat, coughMedDRA releases: 2024-11 · check-in free text available
- 2021-07-29
- 2021-08-05
- 2021-08-12
-
2021-08-19
Survey response — day 42, dose 2MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Cold like symptoms. Runny nose, cough, congestionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-06
Survey response — 6 months, dose 2MedDRA: Cough, Headache, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Fever, cough, runny nose, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-03-17
Dose 3 — Pfizer-BioNTech
-
2022-03-19
Survey response — days 1–6 daily, dose 3MedDRA: Paraesthesia — Feeling: Fair · Site: Pain · Headache, Muscle or body achesFree text: Face tinglingMedDRA releases: 2024-11 · check-in free text available
- 2022-03-20
-
2022-03-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-03-22
- 2022-03-24
- 2022-03-31
- 2022-04-30
-
2022-06-16
Survey response — 3 months, dose 3MedDRA: Gastrointestinal disorder, Nasopharyngitis, Pyrexia — Feeling: Fair · Be unable to work or attend schoolFree text: GI symptoms, fever, cold like symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-02 | Pfizer-BioNTech | |
| 2 | 2021-07-08 | Pfizer-BioNTech | No |
| 3 | 2022-03-17 | Pfizer-BioNTech | No |
Free text
Release 9 — day 21, dose 1
Symptoms: Sore throat, cough, congestion
Release 9 — day 14, dose 2
Symptoms: Sore throat, cough
Release 9 — day 42, dose 2
Symptoms: Cold like symptoms. Runny nose, cough, congestion
Release 10 — 6 months, dose 2
Symptoms: Fever, cough, runny nose, headache
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Face tingling
Release 12 — 3 months, dose 3
Symptoms: GI symptoms, fever, cold like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release